Breast Cancer News

Access the latest in breast cancer research and breakthroughs that influence the way physicians diagnose and treat the disease.

Still can’t get enough breast cancer information? >>Sign up to receive Peer to Peer, our monthly e-mail newsletter.

Below you will find the latest News You Can Use, a monthly list of the most important updates. Bookmark this page and come back again and again to get the latest.

January 2010

Drugs may curb breast cancer
A popular class of bone-building drugs known as bisphosphonates appears to significantly reduce women's risk of breast cancer, according to research presented at the San Antonio Breast Cancer Symposium.

Old ideas spur new approaches in cancer fight
More and more researchers are plunging into murky depths of research, studying tumors in their cellular environments.  And, once they do, they say, they can explain many anomalies of cancer.  The new focus on a cancer’s surroundings, researchers say, is a major shift in thinking about why cancer occurs and how to stop it.

Study questions true favorability of rare breast cancer type
In a large review of breast cancer patients with mucinous carcinoma, researchers at M.D.AndersonCancerCenter have identified an association between this rare type of breast cancer long-associated with a favorable prognosis and multiple tumors undetected by mammography or ultrasound.

Self-seeding of cancer cells may play a critical role in tumor progression
A new study by researchers at Memorial Sloan-Kettering Cancer Center shows that circulating tumor cells—cancer cells that break away from a primary tumor and disseminate to other areas of the body—can also return to and grow in their tumor of origin, a newly discovered process called "self-seeding."

Targeted therapy prolongs life in patients with HER2-positive breast cancer
Lapatinib plus trastuzumab is significantly better than lapatinib alone in extending the lives of
breast cancer patients whose tumors are HER2-positive, according to research conducted at Duke
University Medical Center.

Chronic pain common after breast cancer surgery
Nearly half of breast cancer survivors are plagued by persistent pain years after cancer surgery, researchers at the University of Copenhagen reported.

Novel biologic beats zoledronic acid [Zometa] for bone mets
The investigational monoclonal antibody denosumab relieves painful bone metastases and prevents their serious complications in breast cancer patients better than standard zoledronic acid (Zometa).

Email This Page: